| Rhythm Biosciences Limited (RHY) ORDINARY FULLY PAID |
Health Care |
$15 |
About the Genetype Acquisition
|
14 Jan 2025 9:16AM |
$0.084 |
$0.054 |
fallen by
35.71%
|
|
RHY - Price-sensitive ASX Announcement
Full Release
Key Points
- Rhythm Biosciences has completed an asset acquisition agreement for the Genetype business assets.
- Business integration is targeted for completion in Q1 CY2025.
- The acquisition supports early cancer detection and opens access to a substantial global market.
- It accelerates commercial growth and expands the geographical footprint of Rhythm.
- The geneType product platform is expected to see accelerated sales post-acquisition.
- Rhythm acquired a complete IP portfolio, know-how, and trade secrets related to Genetype.
- The acquisition cost was AUD$625,000 with no legacy debts included.
- Revenue from customer cases after December 24, 2024, will be recognized by Rhythm.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Wellard Limited (WLD) ORDINARY FULLY PAID |
Consumer Staple |
$93 |
Sale of Ocean Drover for USD50M
|
14 Jan 2025 9:15AM |
$0.073 |
$0.175 |
risen by
139.73%
|
|
WLD - Price-sensitive ASX Announcement
Full Release
Key Points
- Wellard Limited selling M/V Ocean Drover for US$50 million.
- The sale requires shareholder approval.
- Expected completion of sale in July 2025.
- Proceeds to be returned to shareholders (approximately A$0.15 per share).
- Sale marks end of Wellard's 46-year involvement in live export.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pengana Private Equity Trust (PE1) ORDINARY UNITS FULLY PAID |
Financials |
$347 |
Update - Notification of buy-back - PE1
|
14 Jan 2025 9:13AM |
$1.385 |
$1.260 |
fallen by
9.03%
|
|
| Alligator Energy Limited (AGE) ORDINARY FULLY PAID |
Energy |
$115 |
Retention Lease Approved - Samphire Field Recovery Trial
|
14 Jan 2025 9:13AM |
$0.037 |
$0.026 |
fallen by
29.73%
|
|
AGE - Price-sensitive ASX Announcement
Full Release
Key Points
- Retention Lease for Field Recovery Trial granted at Samphire Uranium Project
- Conditions of the lease will be incorporated into the Program for Environment Protection and Rehabilitation
- Approval of the PEPR is the final regulatory step before construction can commence
- Pilot processing plant fabrication completed and stored in Whyalla
- Community engagement efforts are ramping up with new appointments
- FRT will assess key parameters for future production operations
- Operations targeted to commence in Q3 2025 and will last three to four months
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Breville Group Limited (BRG) ORDINARY FULLY PAID |
Consumer Discretionary |
$4,405 |
Notice of FY25 First Half Result and Conference Call
|
14 Jan 2025 9:12AM |
$34.830 |
$30.600 |
fallen by
12.14%
|
|
| PM Capital Global Opportunities Fund Limited (PGF) ORDINARY FULLY PAID |
Financials |
$1,242 |
Monthly Report - 31 December 2024
|
14 Jan 2025 9:10AM |
$2.230 |
$2.590 |
risen by
16.14%
|
|
| Condor Energy Limited (CND) ORDINARY FULLY PAID |
Energy |
$16 |
Trading Halt
|
14 Jan 2025 9:09AM |
$0.019 |
$0.023 |
risen by
21.05%
|
|
CND - Price-sensitive ASX Announcement
Full Release
Key Points
- Condor Energy Limited requested a trading halt.
- The halt is due to an upcoming announcement regarding a resource estimate update.
- The trading halt will end when the announcement is released or on 16 January 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| nanollose Limited (NC6) ORDINARY FULLY PAID |
Health Care |
$24 |
Update - Proposed issue of securities - NC6
|
14 Jan 2025 9:08AM |
$0.019 |
$0.080 |
risen by
321.05%
|
|
| Alpha HPA Limited (A4N) ORDINARY FULLY PAID |
Materials |
$1,040 |
Significant Acceleration in Semiconductor Sector Demand
|
14 Jan 2025 9:08AM |
$0.900 |
$0.915 |
risen by
1.67%
|
|
A4N - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant lift in demand from the semiconductor sector identified.
- Increased demand primarily from thermal interface materials and CMP slurries.
- Letter of intent received from a market leader for both Stage 1 and Stage 2 of the HPA First Project.
- Alpha's purification process uniquely matches demanding alumina quality requirements.
- Stage 1 production facility adapting to maximize high purity alumina hydrate production.
- Global semiconductor sector experiencing extraordinary growth driven by AI data centers.
- High purity alumina-based demand for better heat management in large data centers.
- Alpha's materials show higher CMP removal rates at lower temperatures, reducing substrate warping.
- Alpha's purification process removes all radio-nuclide impurities, meeting stringent quality standards.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Nanoveu Limited (NVU) ORDINARY FULLY PAID |
Information Technology |
$56 |
Notification of cessation of securities - NVU
|
14 Jan 2025 9:07AM |
$0.034 |
$0.063 |
risen by
85.29%
|
|
| Incitec Pivot Limited (IPL) ORDINARY FULLY PAID |
Materials |
$4,827 |
Update - Notification of buy-back - IPL
|
14 Jan 2025 9:04AM |
$2.940 |
$2.590 |
fallen by
11.90%
|
|
| Nanosonics Limited (NAN) ORDINARY FULLY PAID |
Health Care |
$1,154 |
Appointment of Non-Executive Director and Appendix 3X
|
14 Jan 2025 9:03AM |
$3.280 |
$3.800 |
risen by
15.85%
|
|
| Vitura Health Limited (VIT) ORDINARY FULLY PAID |
Health Care |
$43 |
Update regarding TGA proceedings
|
14 Jan 2025 9:00AM |
$0.083 |
$0.065 |
fallen by
21.69%
|
|
VIT - Price-sensitive ASX Announcement
Full Release
Key Points
- Vitura Health Limited announced an update regarding TGA proceedings against CDA Clinics Qld.
- Proceedings allege breaches of the Therapeutic Goods Act during 2021.
- CDA Clinics Qld is a dormant entity and not part of Vitura's current operations.
- Vitura is not involved in the alleged breaches and has discontinued funding the defense.
- CDA Clinics Qld is being placed into liquidation.
- The proceedings against CDA Clinics Qld have been stayed.
- Vitura confirms it will not be affected by any court judgment against CDA Clinics Qld.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Keybridge Capital Limited (KBC) ORDINARY FULLY PAID |
Financials |
$10 |
Replacement Notice of General Meeting/Proxy Form
|
14 Jan 2025 9:00AM |
$0.047 |
$0.047 |
fallen by
0%
|
|
| Connexion Mobility Ltd (CXZ) ORDINARY FULLY PAID |
Information Technology |
$22 |
Update - Notification of buy-back - CXZ
|
14 Jan 2025 8:58AM |
$0.026 |
$0.027 |
risen by
3.85%
|
|
| Bioxyne Limited (BXN) ORDINARY FULLY PAID |
Consumer Staple |
$97 |
Addendum to Presentation dated 18 November 2024
|
14 Jan 2025 8:57AM |
$0.027 |
$0.045 |
risen by
69.81%
|
|
BXN - Price-sensitive ASX Announcement
Full Release
Key Points
- Bioxyne aims to exceed revenue guidance of A$20 million.
- Reported revenue of approximately A$12.5 million for H1 FY2025.
- New manufacturing facility expected to be operational in January 2025.
- Diverse customer base with significant supply agreements.
- Estimated A$36.5 million in supply agreements over two years.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mitchell Services Limited (MSV) ORDINARY FULLY PAID |
Materials |
$61 |
Update - Notification of buy-back - MSV
|
14 Jan 2025 8:56AM |
$0.350 |
$0.290 |
fallen by
17.14%
|
|
| Nova Minerals Limited (NVA) ORDINARY FULLY PAID |
Materials |
$99 |
January 2025 Corporate Update Presentation
|
14 Jan 2025 8:56AM |
$0.370 |
$0.250 |
fallen by
32.43%
|
|
| New Hope Corporation Limited (NHC) ORDINARY FULLY PAID |
Energy |
$3,517 |
New Acland Stage 3 Update
|
14 Jan 2025 8:54AM |
$4.880 |
$4.160 |
fallen by
14.75%
|
|
| Cryosite Limited (CTE) ORDINARY FULLY PAID |
Health Care |
$35 |
Cryosite Launches Investor Hub
|
14 Jan 2025 8:53AM |
$0.780 |
$0.710 |
fallen by
8.97%
|
|
| Atomo Diagnostics Limited (AT1) ORDINARY FULLY PAID |
Health Care |
$15 |
Atomo Secures Long Term Agreement with Newfoundland
|
14 Jan 2025 8:52AM |
$0.018 |
$0.020 |
risen by
11.11%
|
|
AT1 - Price-sensitive ASX Announcement
Full Release
Key Points
- Atomo Diagnostics Limited announced a long-term supply agreement with Newfoundland Diagnostics Limited.
- The agreement is valued at approximately A$5.44 million over five years.
- Newfoundland has exclusive rights to distribute Atomo's HIV self-test in the UK.
- Non-exclusive distribution rights are granted for the EU and Colombia.
- An upfront order for 50,000 tests will be manufactured by Atomo this quarter.
- Newfoundland has successfully launched the product in major UK retail chains.
- The partnership aims to further expand into new markets and channels.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Light & Wonder Inc. (LNW) CDI 1:1 FOREIGN EXEMPT XNGS |
Consumer Discretionary |
$12,440 |
Fourth Quarter & Full Year 2024 Results on February 25, 2025
|
14 Jan 2025 8:49AM |
$138.000 |
$148.270 |
risen by
7.44%
|
|
| Dart Mining NL (DTM) ORDINARY FULLY PAID |
Materials |
$4 |
Drilling Recommences at Triumph Project
|
14 Jan 2025 8:48AM |
$0.010 |
$0.003 |
fallen by
70%
|
|
| Amcor Plc (AMC) CDI 1:1 FOREIGN EXEMPT NYSE |
Materials |
$33,589 |
Form S-4
|
14 Jan 2025 8:45AM |
$15.330 |
$14.570 |
fallen by
4.96%
|
|
AMC - Price-sensitive ASX Announcement
Full Release
Key Points
- Amcor and Berry entered into a Merger Agreement on November 19, 2024.
- Berry will become a wholly-owned subsidiary of Amcor after the merger.
- Each share of Berry Common Stock will convert to 7.25 Amcor Ordinary Shares.
- Amcor shareholders will hold approximately 63% of the combined company.
- The merger is expected to strengthen Amcor's market position and product offerings.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| CAR Group Limited (CAR) ORDINARY FULLY PAID |
Communication Services |
$14,000 |
Exit of Tyres business and Group outlook reiteration
|
14 Jan 2025 8:43AM |
$37.500 |
$37.050 |
fallen by
1.20%
|
|
CAR - Price-sensitive ASX Announcement
Full Release
Key Points
- CAR Group exits its Australian Tyres business unit.
- The decision follows challenges in achieving sustainable profitability.
- Assets of tyreconnect will be sold to a third party.
- Tyresales.com.au will close effective January 14, 2025.
- Financial performance will be reported on a proforma basis excluding Tyres.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
